regulatory
confidence high
sentiment negative
materiality 0.85
Applied Molecular Transport Inc.: Nasdaq/NYSE listing notice — Nasdaq deems AMTI a 'public shell' and seeks delisting; company appeals
Applied Molecular Transport Inc.
- On Aug 10, 2023, Nasdaq Staff notified AMTI it believes the company is a 'public shell' and listing is no longer warranted.
- Also, AMTI failed to maintain minimum $1.00 bid price per Nasdaq Listing Rule 5450(a)(1).
- Company disagrees with the 'public shell' determination, citing ongoing clinical, IP, and business development operations.
- AMTI will appeal to Nasdaq Hearings Panel; delisting is stayed pending Panel decision.
- No assurance of success in appeal; risk of delisting if compliance not regained.